Related Experiment Video
Updated: Jan 24, 2026

10:02
High-frequency Ultrasound Imaging of Mouse Cervical Lymph Nodes
Published on: July 25, 2015
19.7K
Establishing a Cervical Cytology Biorepository: A Protocol for Advancing Translational Cervical Cancer Research
Bahira Ahmed1, Sadia Sayeed2, Ciara Rhodes3
1School of Medicine, Virginia Commonwealth University, Richmond, Virginia.
Summary
A new cervical cytology biorepository was established to study cervical cancer risk and disparities. This resource enables multi-omic analyses using residual Pap specimens, supporting biomarker discovery and research into gynecologic health.
Area of Science:
- Gynecologic Oncology
- Molecular Epidemiology
- Biobanking
Background:
- Cervical cancer is a global health issue with screening disparities, especially in young US women.
- High-risk HPV is the main cause, but environmental factors need more study.
- The VCU Cervical Cytology Biorepository was created to research cervical cancer risk, biomarkers, and health disparities.
Purpose of the Study:
- To establish a cervical cytology biorepository using residual Pap specimens.
- To support research into the causes of cervical cancer and gynecologic health disparities.
- To enable multi-omic analyses for biomarker discovery.
Main Methods:
- Standardized protocols for recovery, processing, and storage of residual ThinPrep Pap specimens (ages 21-65).
- Utilized an opt-out consent model and IRB-approved waiver for discarded cytology.
- Integrated electronic health records for longitudinal clinical data and cryostored specimens at -80°C.
Main Results:
- The biorepository enables standardized processing of residual Pap specimens for genomic DNA extraction and metabolomic profiling.
- Pilot data confirm adequate input for multi-omic analyses from residual cervical cytology.
- Demonstrated feasibility and scalability of the biorepository protocol.
Conclusions:
- A framework for establishing a cervical cytology biobank from residual clinical specimens was developed.
- Linking biospecimens with clinical and demographic data facilitates research on cervical cancer and gynecologic conditions.
- This resource supports molecular epidemiology for biomarker identification and addressing reproductive health disparities.
Related Concept Videos
Translation
155.9K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
155.9K
Translation
17.7K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
17.7K
Initiation of Translation
38.4K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.4K
Termination of Translation
27.5K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.5K
Termination of Translation
6.6K
6.6K
Improving Translational Accuracy
14.1K
Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
14.1K

